Literature DB >> 18398681

The differential effect of endothelial cell factors on in vitro motility of malignant and non-malignant cells.

Adele Wright1, Yu-Hua Li, Cheng Zhu.   

Abstract

Motility of cancer cells plays a critical role in tumor metastasis, and as such is a target for intervention. The motility of malignant Calu-1 human lung epithelial carcinoma cells is upregulated when placed on a human umbilical vein endothelial cell monolayer, while that of non-malignant L132 human lung epithelial cells is not. To dissect the factor(s) causing such differential behaviors, the motile responses of both cell lines to endothelial cell factors-secreted to the media, on the endothelial cell surface, and secreted to the extracellular matrix-and to individual extracellular matrix proteins were compared. Cell motility was quantified by tracking the cell movement on a surface with time-lapse video microscopy, which was analyzed with the persistent random walk model of motility. None of the factors tested had a remarkable effect on L132 cell motility, but the Calu-1 cell motility was significantly upregulated by endothelial cell extracellular matrix and by laminin, fibronectin, collagen I and collagen VI individually. Flow cytometry analysis revealed significantly higher expression levels of integrin subunits beta1, alpha2, alpha3, and alpha6, which are known receptors for these extracellular matrix proteins, on the Calu-1 than L132 cells, implicating a role of these integrins in the observed motile behaviors of these cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398681      PMCID: PMC2504021          DOI: 10.1007/s10439-008-9489-9

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  26 in total

1.  Alpha4beta1 and alpha5beta1 control cell migration on fibronectin by differentially regulating cell speed and motile cell phenotype.

Authors:  J H Chon; R Netzel; B M Rock; E L Chaikof
Journal:  Ann Biomed Eng       Date:  1998 Nov-Dec       Impact factor: 3.934

2.  Modulation of in vivo migratory function of alpha 2 beta 1 integrin in mouse liver.

Authors:  W C Ho; C Heinemann; D Hangan; S Uniyal; V L Morris; B M Chan
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

3.  Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion.

Authors:  R H Kramer; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins.

Authors:  D R Friedlander; D Zagzag; B Shiff; H Cohen; J C Allen; P J Kelly; M Grumet
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

Review 5.  The laminin family.

Authors:  K Tryggvason
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

6.  Biased random walk models for chemotaxis and related diffusion approximations.

Authors:  W Alt
Journal:  J Math Biol       Date:  1980-04       Impact factor: 2.259

7.  Assessment of brain tumor cell motility in vivo and in vitro.

Authors:  M R Chicoine; D L Silbergeld
Journal:  J Neurosurg       Date:  1995-04       Impact factor: 5.115

8.  Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction.

Authors:  R J Garden; B C Liu; S M Redwood; R E Weiss; M J Droller
Journal:  J Urol       Date:  1992-09       Impact factor: 7.450

9.  Dispersive locomotion of human neutrophils in response to a steroid-induced factor from monocytes.

Authors:  S Chettibi; A J Lawrence; J D Young; P D Lawrence; R D Stevenson
Journal:  J Cell Sci       Date:  1994-11       Impact factor: 5.285

10.  Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner.

Authors:  M F Ware; A Wells; D A Lauffenburger
Journal:  J Cell Sci       Date:  1998-08       Impact factor: 5.285

View more
  6 in total

1.  Expression of COL6A1 predicts prognosis in cervical cancer patients.

Authors:  Teng Hou; Chongjie Tong; Gallina Kazobinka; Weijing Zhang; Xin Huang; Yongwen Huang; Yanna Zhang
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Integrin dependence of Calu-1 cell motility on endothelial extracellular matrix proteins.

Authors:  Adele Wright; Yu-Hua Li; Cheng Zhu
Journal:  Ann Biomed Eng       Date:  2008-04-09       Impact factor: 3.934

Review 3.  Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis.

Authors:  Ana C Martins Cavaco; Sara Dâmaso; Sandra Casimiro; Luís Costa
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer - A Proof of Concept Study.

Authors:  Nicholas Willumsen; Cecilie Bager; Morten A Karsdal
Journal:  Transl Oncol       Date:  2019-03-09       Impact factor: 4.243

Review 5.  Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology.

Authors:  Neel I Nissen; Morten Karsdal; Nicholas Willumsen
Journal:  J Exp Clin Cancer Res       Date:  2019-03-06

6.  Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.

Authors:  Neel I Nissen; Stephanie Kehlet; Mogens K Boisen; Maria Liljefors; Christina Jensen; Astrid Z Johansen; Julia S Johansen; Janine T Erler; Morten Karsdal; Joachim H Mortensen; Anette Høye; Nicholas Willumsen
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.